When was Loyal founded?

Loyal was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Loyal located?

Loyal is headquartered in San Francisco, United States.

Who is the current CEO of Loyal?

Celine Halioua of Loyal. They have also founded 2 companies and are an angel investors in 1 startup.

How many employees does Loyal have?

As of Aug 31, 2026, the latest employee count at Loyal is 219.

Is Loyal a funded company?

Loyal is a funded company, having raised a total of $250M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2020.

How much is Loyal worth?

The latest valuation of Loyal is $***** as of Aug 12, 2025.

When was the latest funding round of Loyal?

Loyal's latest funding was a $***** Series C round on Feb 11, 2026, with participation from 2 investors.

Where does Loyal rank among its competitors?

Loyal ranks 1st amongst 60 active competitors, of which 13 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Loyal, which secured $100M in Feb, 2026.

Who are the top competitors of Loyal?

Loyal's top competitors include Gallant, Anivive and Vétoquinol. Among them, Loyal secured the most recent funding round in February, 2026.

Loyal - 2026 Company Profile, Team, Funding & Competitors

Loyal is a series C company based in San Francisco (United States), founded in 2020 by Celine Halioua. It operates as a Provider of therapeutics for the treatment of dogs health. Loyal has raised $250M in funding from investors like Khosla Ventures, Bain Capital Ventures and Valor Equity Partners, with a current valuation of $*****. The company has 60 active competitors, including 13 funded and 5 that have exited. Its top competitors include companies like Gallant, Anivive and Vétoquinol.

Company Details

Provider of therapeutics for the treatment of dogs health. It offers LOY-002 forthe treatment of metabolic dysfunction in large dogs, LOY-001, and LOY-003 for crrecting overexpression of IGF-1 and growth hormone (GH) in large dogs.

Website: loyal.com
Social
Email ID: *****@loyal.com

Key Metrics

Founded Year

2020

Location

San Francisco, United States

Stage

Series C

Total Funding

$250M in 5 rounds

Latest Funding Round

Series C, Feb 11, 2026, $*****

Post Money Valuation

$***** as on Aug 12, 2025

Investors

Khosla Ventures & 18 more

Ranked

1^st among 60 active competitors

Employee Count

219 as on Aug 31, 2026

Similar Companies

Anivive & 43 more

View Loyal's full profile

Loyal has raised a total funding of $250M over 5 rounds. Its first funding round was on 2020. Its latest funding round was a Series C round on Feb 11, 2026 for $*****. 2 investors participated in its latest round. Loyal has 18 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Loyal:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 11, 2026	6455456	Series C	3862018	4856511	9394086	3148781
Feb 26, 2025	6083898	Series B	3519089	6341551	3995627	Collab Fund
Mar 05, 2024	2369427	Series B	5595999	4282235	Bain Capital Ventures	Valor Equity Partners & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Loyal's funding rounds and investors

The founders of Loyal is Celine Halioua. Celine Halioua is the CEO of Loyal.

Here are the details of Loyal's key team members:

Celine Halioua: Founder & CEO of Loyal and founder of 1 other company. They are also an angel investor in 1 startup.
Contact Info: 2 email addresses

View details of Loyal's Founder profiles and Board Members

Loyal's employee count trend

Loyal has 219 employees as of Aug 26. Here is Loyal's employee count trend over the years:

Uncover Loyal's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Loyal include Gallant, Anivive and Vétoquinol. Here is the list of Top 10 competitors of Loyal, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Loyal 2020, San Francisco (United States), Series C	Provider of therapeutics for the treatment of dogs health	$250M	Baillie Gifford, First Round Capital & 17 others	58/100
2nd	Gallant 2018, Los Angeles (United States), Series B	Provider of stem cell based regenerative therapy for dogs	$61.5M	Bold Capital Partners, Digitalis Ventures ... & 13 others	55/100
3rd	Anivive 2015, Long Beach (United States), Series C	Developer of therapeutics for animals	$44.3M	LEONID, FDA & 1 others	55/100
4th	Vétoquinol 1933, Lure (France), Public	Developer of therapeutics drugs for animal health	-	Economy And Finance, Azulis Capital	53/100
5th	Bioceltix 2017, Wroclaw (Poland), Seed	Developer of drugs for veterinary therapy	-	Infini, Leonarto	48/100
6th	Invetx 2018, Boston (United States), Acquired	Provider of pharmaceutical products like protein-based therapeutics for pets	$86M	F-Prime Capital, Novo Holdings & 7 others	45/100
7th	ZYMOX 1999, Westmont (United States), Unfunded	Provider of enzyme-based pet care and therapeutics products	-	-	45/100
8th	VetStem 2002, Poway (United States), Unfunded	Developer of vet stem cell therapy for animal health	-	-	43/100
9th	Felixvet 2014, Dublin (Ireland), Late Stage	Manufacturer of generic and complex veterinary pharmaceuticals for companion animals	-	Advent International	40/100
10th	eQcell 2010, Guelph (Canada), Series A	Developer of stem cell therapies for the treatment of animals	$4.6M	Accelerator Centre, Ag Capital Canada	37/100